Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QMix vs EDTA and Chlorhexidine in Endodontic Therapy
NCT03853200Phase 3Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Apr 2017
- Primary completion
- Feb 2018
- Modality
- SOLN (Solution)
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of QMix in Endodontic infection, sponsored by Dow University of Health Sciences. Primary endpoint: Change in Colony Forming Unit at 5 minutes. Started Apr 2017; status: completed.
02
Drugs
QMix
03
Conditions
Endodontic infection
Beyond the preview
Go deeper on NCT03853200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03853200.